freepeople性欧美熟妇, 色戒完整版无删减158分钟hd, 无码精品国产vα在线观看DVD, 丰满少妇伦精品无码专区在线观看,艾栗栗与纹身男宾馆3p50分钟,国产AV片在线观看,黑人与美女高潮,18岁女RAPPERDISSSUBS,国产手机在机看影片

正文內(nèi)容

20xx年醫(yī)學專題—肺癌的診治指南-文庫吧資料

2024-11-14 18:27本頁面
  

【正文】 imary tumor, treatment is determined by establishing the stage of the patient’s tumor. Therapy is identical to that recommended for other nonsmall cell lung cancer patients with similar stage disease.,第五十頁,共六十三頁。); 序貫; /選擇其中之一,第四十九頁,共六十三頁。bāo)肺癌的治療原則和療效,注:+同時(t243。nz233。); 序貫; /選擇其中之一,第四十八頁,共六十三頁。bāo)肺癌的治療原則和方法(3),非小細胞肺癌的治療原則和療效 注:+同時(t243。); 序貫; /選擇其中之一,第四十七頁,共六十三頁。)和方法(2),非小細胞肺癌的治療原則和療效 注:+同時(t243。,非小細胞肺癌的治療原則(yu225。,第四十五頁,共六十三頁。,第四十三頁,共六十三頁。,第四十一頁,共六十三頁。,第三十九頁,共六十三頁。,第三十七頁,共六十三頁。,第三十五頁,共六十三頁。bāo)肺癌的治療方法,第三十三頁,共六十三頁。i 225。,NCI guideline:Treatment of ED SCLC (4),3. Identification of effective new agents is difficult in patients who have previously been treated with standard chemotherapy because response rates to agents, even of known efficacy, are known to be lower than in previously untreated patients. This situation led to the suggestion that patients with extensive disease who are medically stable be treated with new agents under evaluation, with provisions for early change to standard combination therapy if there is no response.[35] Such a strategy has been shown to be feasible, with survival comparable to survival with initial standard therapy, as long as the patients with extensive disease are carefully chosen.[3638] A variety of other strategies have been proposed, depending on the activity of the new agent in other tumors, in preclinical small cell lung cancer models, or the activity of drug analogs.[39] Active single agents undergoing further evaluation include paclitaxel and topotecan.[40,41],第三十二頁,共六十三頁。,NCI guideline:Treatment of ED SCLC (2),Other regimens appear to produce similar survival outcomes but have been studied less extensively or are in less common use, including: Cyclophosphamide + doxorubicin + etoposide + vincristine.[32] CEV: cyclophosphamide + etoposide + vincristine.[33] Singleagent etoposide.[21] PET: cisplatin + etoposide + paclitaxel.[34],第三十頁,共六十三頁。,NCI guideline:Treatment of LD SCLC,Standard treatment options: 1.Combination chemotherapy with chest irradiation (with or without PCI given to patients with complete responses): EC: etoposide + cisplatin + 4500 cGy chest radiation therapy. 2.Combination chemotherapy (with or without PCI in patients with complete responses), especially in patients with impaired pulmonary function or poor performance status. 3.Surgical resection followed by chemotherapy or chemothera
點擊復制文檔內(nèi)容
小學相關推薦
文庫吧 www.dybbs8.com
備案圖鄂ICP備17016276號-1